GFAP and central nervous system cancer: WHO classification of MPE is primarily based on histological features, with essential diagnostic criteria being defined as a “glioma with papillary structures and perivascular myxoid change or at least focal myxoid microcysts AND immunoreactivity for glial fibrillary acidic protein (GFAP)” [25].